Positrigo
Positrigo AG is a private nuclear medical imaging start-up based in Zurich, Switzerland, founded by Max Ahnen, Jannis Fischer, Alfred Buck, Guenther Dissertori, Werner Lustermann and Bruno Weber. Positrigo is focusing on developing ultra-compact PET systems. Positrigo's technology, development and clinical program are supported by investors 4FO Venture Partners, Great Filter Ventures, Zuercher Kantonalbank (ZKB), ETH Zurich Foundation and Venture Kick. Positrigo is further supported by the European Union research and innovation program Horizon 2020 (grant nos. 855292 and 953844), and by Innosuisse. The BPET prototype was developed at ETH Zurich with the generous support of an ETH Zurich Pioneer Fellowship, of Innosuisse, of the ETH Zurich Foundation, and of Dr. Stephan and Dr. Viktoria Schmidheiny.
About Positrigo
Founded
2018Estimated Revenue
$0-$1MEmployees
11-50Funding / Mkt. Cap
$14MCategory
Industry
Medical DevicesLocation
City
ZürichState
ZurichCountry
SwitzerlandPositrigo
Find your buyer within Positrigo